|
Video: What is a Stock Split?
|
|
Genenta Science is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. Co. has developed a biologic platform that involves the ex-vivo gene transfer of a therapeutic candidate into autologous hematopoietic stem or progenitor cells (HSPCs) to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes or macrophages (Tie2 Expressing Monocytes - TEMs). Co.'s technology is designed to turn TEMs into a "Trojan Horse" to counteract cancer progression and to prevent tumor relapse. According to our Genenta Science SpA stock split history records, Genenta Science SpA has had 1 split. | |
|
Genenta Science SpA (GNTA) has 1 split in our Genenta Science SpA stock split history database. The split for GNTA took place on April 07, 1997. This was a 1 for 10 reverse split, meaning for each 10 shares of GNTA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Genenta Science SpA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Genenta Science SpA stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Genenta Science SpA shares, starting with a $10,000 purchase of GNTA, presented on a split-history-adjusted basis factoring in the complete Genenta Science SpA stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/16/2021 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$11.25 |
|
End price/share: |
$2.59 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-76.98% |
|
Average Annual Total Return: |
-46.35% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,301.87 |
|
Years: |
2.36 |
|
|
|
Date |
Ratio |
04/07/1997 | 1 for 10 |
|
|